SCHEMBL756175

SCHEMBL756175

CC(C)(C)OC(=O)NNC(=O)CNC(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.56
ALDH1A1 P00352 1/20 0.53
MAPK1 P28482 1/20 0.51
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAPT P10636 1/20 0.49
CTSL P07711 1/20 0.49
CTSB P07858 1/20 0.49
CTSS P25774 1/20 0.49
CTSK P43235 1/20 0.49
PRSS1 P07477 1/20 0.49
TPSAB1 Q15661 1/20 0.49
TPSD1 Q9BZJ3 1/20 0.49
TPSG1 Q9NRR2 1/20 0.49
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA7 P43166 1/20 0.48
CA14 Q9ULX7 1/20 0.48
HTT P42858 2/20 0.48
MEN1 O00255 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25552740 0.88 ALDH1A1 (0.50) SYKALDH1A1MAPK1LMNASMN1; SMN2
SCHEMBL421286 0.87 SYK (0.61) SYKALDH1A1LMNASMN1; SMN2MAPT
SCHEMBL30544325 0.87 SYK (0.57) SYKALDH1A1MAPK1LMNASMN1; SMN2
SCHEMBL25908037 0.86 ALDH1A1 (0.53) SYKALDH1A1MAPK1LMNASMN1; SMN2
SCHEMBL6932926 0.86 ALDH1A1 (0.53) SYKALDH1A1MAPK1LMNASMN1; SMN2
SCHEMBL19295062 0.86 PRSS1 (0.44) SYKALDH1A1MAPK1MAPTPRSS1
SCHEMBL12475781 0.86 SYK (0.62) SYKALDH1A1MAPK1LMNASMN1; SMN2
SCHEMBL7907133 0.86 SYK (0.62) SYKALDH1A1MAPK1LMNASMN1; SMN2
SCHEMBL6016839 0.86 SYK (0.57) SYKALDH1A1MAPK1LMNASMN1; SMN2
SCHEMBL22657971 0.86 SYK (0.56) SYKALDH1A1MAPK1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12060333-B2 Aminocarbamoyl compounds for the treatment of viral infections HOFFMANN-LA ROCHE INC. (US) 2024-08-13 US disclosed
US-20230277677-A1 POLYMERIC CONJUGATES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2023-09-07 US disclosed
EP-4204393-A1 AMINOCARBAMOYL COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS F. Hoffmann-La Roche AG (CH) 2023-07-05 EP disclosed
US-11666656-B2 Polymeric conjugates and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2023-06-06 US disclosed
WO-2022043374-A1 AMINOCARBAMOYL COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS F. HOFFMANN-LA ROCHE AG (CH) 2022-03-03 WO disclosed
WO-2017145164-A1 POLYMERIC CONJUGATES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2017-08-31 WO disclosed
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators PFIZER INC. (US) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053165-A1 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators BACE1, BACE2, PSEN1 SYK 2765/4885ALDH1A1 1903/4885MAPK1 2988/4885
US-11666656-B2 Polymeric conjugates and uses thereof CD44, DCLRE1A, CD74 SYK 2854/4885ALDH1A1 2653/4885MAPK1 3732/4885
US-20230277677-A1 POLYMERIC CONJUGATES AND USES THEREOF CD44, DCLRE1A, CD74 SYK 2854/4885ALDH1A1 2653/4885MAPK1 3732/4885
US-12060333-B2 Aminocarbamoyl compounds for the treatment of viral infections SARS1, BCAT1, SLC1A5 SYK 4012/4885ALDH1A1 2749/4885MAPK1 3502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.